Pektaş Ayhan, Kara Ateş, Gurgey Aytemiz
Afyon Kocatepe University Faculty of Medicine Hospital, Department of Pediatrics, Afyonkarahisar, Turkey Phone: +90 (272) 246 33 33 E-mail:
Turk J Haematol. 2015 Jun;32(2):144-51. doi: 10.4274/tjh.2013.0403.
This study aims to document and analyze the central venous catheter (CVC)-related complications in children with hematological diseases who were treated within a single institution.
A retrospective investigation was conducted in 106 pediatric patients in whom 203 CVCs were inserted. A total of 175 catheter-related complications occurred in 5 years.
The rates of clinical catheter infections, local catheter infections, venous thromboembolism, bleeding, and mechanical complications were 2.6, 1.1, 0.2, 0.2, and 0.2 per 1000 catheter days. Methicillin-resistant Staphylococcus epidermidis was the predominant infectious organism in blood and catheter cultures. The children with leukemia had a significantly higher frequency of clinical catheter infections (p=0.046). The children who underwent bone marrow transplantation had a significantly lower frequency of clinical catheter infections (p=0.043) and higher frequency of local catheter infections (p=0.003). The children with implanted catheters had a significantly lower frequency of clinical catheter infections (p=0.048). The children with thrombocytopenia had significantly fewer local catheter infections and significantly more clinical catheter infections and catheter-related bleeding (respectively p=0.001, p=0.042, and p=0.024).
Leukemia, bone marrow transplantation, and thrombocytopenia are risk factors for CVC-associated complications. The relatively higher number of interventions performed via permanent catheters may be responsible for the significantly increased incidence of systemic infections and mechanical injury.
本研究旨在记录和分析在单一机构接受治疗的血液系统疾病患儿中心静脉导管(CVC)相关并发症。
对106例插入203根CVC的儿科患者进行回顾性调查。5年内共发生175例导管相关并发症。
临床导管感染、局部导管感染、静脉血栓栓塞、出血和机械并发症的发生率分别为每1000导管日2.6、1.1、0.2、0.2和0.2例。耐甲氧西林表皮葡萄球菌是血液和导管培养中主要的感染病原体。白血病患儿临床导管感染的发生率显著更高(p = 0.046)。接受骨髓移植的患儿临床导管感染的发生率显著更低(p = 0.043),局部导管感染的发生率显著更高(p = 0.003)。植入导管的患儿临床导管感染的发生率显著更低(p = 0.048)。血小板减少症患儿局部导管感染显著更少,临床导管感染和导管相关出血显著更多(分别为p = 0.001、p = 0.042和p = 0.024)。
白血病、骨髓移植和血小板减少症是CVC相关并发症的危险因素。通过永久性导管进行的干预操作数量相对较多可能是全身感染和机械损伤发生率显著增加的原因。